Posaconazole: A Broad-Spectrum Triazole Antifungal Agent
Open Access
- 15 December 2007
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 45 (12) , 1610-1617
- https://doi.org/10.1086/523576
Abstract
Posaconazole is a triazole antifungal agent with a spectrum of activity that includes Candida and Cryptococcus species, many molds, and some endemicKeywords
This publication has 75 references indexed in Scilit:
- Reviews Of Anti‐infective Agents: Anidulafungin: A Novel EchinocandinClinical Infectious Diseases, 2006
- Posaconazole: a broad-spectrum triazole antifungalThe Lancet Infectious Diseases, 2005
- Second-generation azole antifungal agentsDrugs of Today, 2005
- Zygomycosis in neutropenic patients with past Aspergillus infection: a role for posaconazole?Clinical Microbiology & Infection, 2004
- Guidelines for Treatment of CandidiasisClinical Infectious Diseases, 2004
- Voriconazole: A New Triazole Antifungal AgentClinical Infectious Diseases, 2003
- High Rate of Invasive Fungal Infections Following Nonmyeloablative Allogeneic TransplantationClinical Infectious Diseases, 2003
- Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant RecipientsClinical Infectious Diseases, 2002
- Invasive Mold Infections in Allogeneic Bone Marrow Transplant RecipientsClinical Infectious Diseases, 2001
- The New Fungal Opportunists Are ComingClinical Infectious Diseases, 1996